Overview
FRANKFURT – McDermott Will & Emery advised private equity firm VR Equitypartner on the acquisition of a minority stake in a cosmetics company Dr Neuberger Group. Its founder, Dr Tobias Neuberger, remains its majority shareholder and managing director. The transaction is subject to approval by relevant antitrust authorities.
VR Equitypartner, a subsidiary of DZ BANK, is one of the leading equity financers in Germany, Austria and Switzerland. VR Equitypartner’s portfolio currently comprises around 100 investments, particularly in medium-sized family businesses, with an investment volume of EUR 500 million.
The Dr Neuberger Group develops and distributes decorative cosmetic products such as eye shadows, nail polishes, artificial eyelashes and accessories, besides cosmetic sets for adults and children. In addition to its own brands and license business, the Group also distributes trade and distribution brands through its individual companies. The products are sold internationally through food retailers, drugstores, perfumeries, toy shops and online shops. The products are manufactured by certified contract manufacturers in Asia, the USA and Europe.
The multidisciplinary McDermott team advising VR Equitypartner was let by Transactions partners Michal Cziesla and Norman Wasse, and included partners Oliver Hahnelt (Finance), Nina Siewert (Tax), Volker Teigelkötter (Employment), Jens Ortmanns (Real Estate) and Alexa Ningelgen (Public Law).
About McDermott Will & Emery
McDermott Will & Emery is a premier international law firm with a diversified business practice. Numbering more than 1,000 lawyers, we have offices in Boston, Brussels, Chicago, Dallas, Düsseldorf, Frankfurt, Houston, London, Los Angeles, Miami, Milan, Munich, New York, Orange County, Paris, San Francisco, Seoul, Silicon Valley and Washington, DC. Further extending our reach into Asia, we have a strategic alliance with MWE China Law Offices in Shanghai. www.mwe.com
